Samsung Nears European Approval for Near-Replica Version of Arthritis Drug

Samsung Group’s drug-development arm said it is on track to win European regulatory approval for a near-replica version of Johnson & Johnson’s blockbuster rheumatoid arthritis drug Remicade.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news